Sort
25,944 grants matching “neurodegeneration”
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimerâs disease
$1,074,815Srikant Rangaraju · Emory University · R01 · FY2022 · AG
Biomarkers of Parkinson Disease and Related Disorders
$1,073,634David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Elucidating the biological differences between distinct fibrillar and non-fibrillar alpha-synuclein inclusions in human stem-cell models
$1,073,530Vikram Khurana · Brigham And Women'S Hospital · R01 · FY2021 · NS
Environmental, Genetic and Cellular Determinants of PD
$1,073,084James William Langston · Parkinson'S Institute · U54 · FY2006 · ES
Early Onset AD Consortium - the LEAD Study (LEADS)
$1,072,053Liana G Apostolova · Indiana University Indianapolis · U01 · FY2021 · AG
Enzyme replacement therapy for GM1 gangliosidosis lysosomal rare disease
$1,071,897David Radin · Biostrategies, Lc · R44 · FY2018 · NS
Brain Banking Core
$1,070,165Edward Byung-Ha Lee · University Of Pennsylvania · U54 · FY2020 · NS
Medical Retina Fellowship
$1,070,068Catherine Cukras · National Eye Institute · ZIE · FY2023 · EY
New Mexico Alzheimer's Disease Research Center
$1,069,505Gary Allen Rosenberg · University Of New Mexico Health Scis Ctr · P20 · FY2020 · AG
Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential
$1,068,798Matthew S. Gentry · University Of Florida · R35 · FY2025 · NS
Mitochondrial Integrated Stress Response in Neurological Diseases
$1,068,698Giovanni Manfredi · Weill Medical Coll Of Cornell Univ · R35 · FY2024 · NS
BIOLOGY OF SPATIOTEMPORAL NITRIC OXIDE GRADIENTS
$1,067,446University Of Wyoming · P20 · FY2004 · RR
Development of an Agonist of the TGF-beta Signaling Pthway to Treat Alzheimer's
$1,067,411Tony Wyss-Coray · Palo Alto Veterans Instit For Research · U01 · FY2013 · NS
Integrated Center for In Vivo Microscopy
$1,066,168Duke University · P41 · FY2005 · RR
Investigating the role of TMEM106b genetics and pathology in Alzheimerâs disease, LATE and FTLD
$1,064,348Leonard Petrucelli · Mayo Clinic Jacksonville · R01 · FY2024 · NS
Aminergic Function in Brain Aging and Alzheimer's Disease
$1,064,113Paula C Bickford · University Of South Florida · P01 · FY2008 · AG
Genetic Mechanisms Controlling Resilience to Huntington's Disease
$1,063,467Catherine Cook Kaczorowski · Jackson Laboratory · R01 · FY2022 · NS
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimerâs disease
$1,063,165Srikant Rangaraju · Emory University · R01 · FY2023 · AG
Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential
$1,063,004Matthew S. Gentry · University Of Florida · R35 · FY2023 · NS
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
$1,061,357Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2024 · AA
Cell Signaling and Neurodegeneration
$1,060,867Harry T. Orr · University Of Minnesota · R01 · FY2009 · NS
OXIDATIVE AND EXCITATORY TOXICITY IN NEURODEGENERATION
$1,060,670Massachusetts General Hospital · P01 · FY2003 · AG
Investigating the role of TMEM106b genetics and pathology in Alzheimerâs disease, LATE and FTLD
$1,060,236Leonard Petrucelli · Mayo Clinic Jacksonville · R01 · FY2025 · NS
Brain fluid clearance and misfolded protein dynamics following traumatic brain injury
$1,059,115Tracy A. Butler · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AG
Magnetic Resonance Imaging Technology Development
$1,056,593Jozef H Duyn · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS